Correct. As “handy” as these rebates will be to the company’s operational cash flow, it’s the actual trial results that I’m focused on... as no doubt you are as well.
The progress on the ARDS trial has been extraordinary IMO... all permits and products sourced. If the animal studies commence soon and are successful then IHL may conduct in-human testing under the EUA (Emergency Use Authorisation) and the SAS which provides an accelerated pathway to drug commercialization.
